Bioreducible Phosphonoamidate Pro-drug Inhibitor of Enolase: Proof of Concept Study

[Image: see text] Glycolysis inhibition remains aspirational in cancer therapy. We recently described a promising phosphonate inhibitor of enolase for cancers harboring homozygous deletions of ENO1. Here, we describe the application of a nitroheterocycle phosphonoamidate pro-drug pair to capitalize...

詳細記述

保存先:
書誌詳細
出版年:ACS Med Chem Lett
主要な著者: Yan, Victoria C., Yang, Kristine L., Ballato, Elliot S., Khadka, Sunada, Shrestha, Prakriti, Arthur, Kenisha, Georgiou, Dimitra K., Washington, Mykia, Tran, Theresa, Poral, Anton H., Pham, Cong-Dat, Yan, Matthew J., Muller, Florian L.
フォーマット: Artigo
言語:Inglês
出版事項: American Chemical Society 2020
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7357215/
https://ncbi.nlm.nih.gov/pubmed/32676158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.0c00203
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料